diabetestalk.net

Metformin And Align

Metformin And Probiotic Interaction | Treato

Metformin And Probiotic Interaction | Treato

Probiotic and Pain Metformin and PCOS Probiotic and Diarrhea Metformin and Diabetes Probiotic and Candida Metformin and Clomid Probiotic and Intestinal Flora Modifiers Metformin and Weight Loss Probiotic and Antibiotics Metformin and Insulin Resistance Treato does not review third-party posts for accuracy of any kind, including for medical diagnosis or treatments, or events in general. Treato does not provide medical advice, diagnosis or treatment. Usage of the website does not substitute professional medical advice. The side effects featured here are based on those most frequently appearing in user posts on the Internet. The manufacturer's product labeling should always be consulted for a list of side effects most frequently appearing in patients during clinical studies. Talk to your doctor about which medications may be most appropriate for you. The information reflected here is dependent upon the correct functioning of our algorithm. From time-to-time, our system might experience bugs or glitches that affect the accuracy or correct application of mathematical algorithms. We will do our best to update the site if we are made aware of any malfunctioning or misapplication of these algorithms. We cannot guarantee results and occasional interruptions in updating may occur. Please continue to check the site for updated information. Continue reading >>

Metformin Drug Interactions

Metformin Drug Interactions

A total of 702 drugs (4976 brand and generic names) are known to interact with metformin. Show all medications in the database that may interact with metformin. Check for interactions with metformin Type in a drug name and select a drug from the list. Common medications checked in combination with metformin metformin alcohol/food Interactions There is 1 alcohol/food interaction with metformin FDA-Approved Weight-Loss Drug - Once-Daily Treatment Need Obesity Help? Learn About an Option That May Help You Reach Your Goal. Prescription treatment website metformin disease Interactions There are 4 disease interactions with metformin which include: The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables. Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. Unknown No information available. Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, Continue reading >>

What Do You Think Of Probiotics?

What Do You Think Of Probiotics?

Im just alittle hesitant to but bacteria in my body although I know its the good kind. Make me alittle skiddish!! haha. But I really want to try it. My friend also suggested Aloe Vera juice from Whole Foods or Trader Joes. She says to drink 2 oz a day. It doesnt taste that bad and it is supposed to help your stomach as well Riley- you bought yours at Whole Foods? Do you know the name of it? I would prefer taking only 1a day. Im not a good pill taker. (you should see my take my daily prenatal. Its pretty comical!!) Im just alittle hesitant to but bacteria in my body although I know its the good kind. Make me alittle skiddish!! haha. But I really want to try it. My friend also suggested Aloe Vera juice from Whole Foods or Trader Joes. She says to drink 2 oz a day. It doesnt taste that bad and it is supposed to help your stomach as well Riley- you bought yours at Whole Foods? Do you know the name of it? I would prefer taking only 1a day. Im not a good pill taker. (you should see my take my daily prenatal. Its pretty comical!!) When I think about being pregnant and having a group of cells grow inside my uterus, that is how I feel. A little skeeved out. So I try to only think of it as a baby, not a group of cells. lol Breastfeeding, co-sleeping, baby wearing, cloth diapering family! Continue reading >>

Hba1c Not Aligning With Home Testing?

Hba1c Not Aligning With Home Testing?

Diabetes Forum The Global Diabetes Community This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies. Learn More. Get the Diabetes Forum App for your phone - available on iOS and Android . Find support, ask questions and share your experiences. Join the community Discussion in ' Prediabetes ' started by Glink , Jul 11, 2017 . I'm going to try to rephrase this for clarity (original post below) to see if that gets any responses. My situation is: I've had fairly steadily rising FBG readings on my home metre, and random-seeming highs throughout the day (I can feel them; get shaky and then test at 7.7-11 several hours after eating anything). But, I get quarterly blood tests and my HbA1c is still great (always 5.3-5.6). My home metre seems calibrated with the FBG drawn at the lab, so I don't think it's off. I thought for sure this recent HbA1c would reflect what feels like a turn for the worse and I could discuss what to do about it with my doctor, but with only my home readings to go on I doubt he'll see anything to discuss. My questions are: Has anyone else experienced this kid of thing? What are the possible explanations for HbA1C being good while other numbers are looking more and more diabetic? I get quarterly blood tests, and test most days at least once on my home metre. I try to control my sugars using a LCHF diet and metformin. When my sugars are high, I fast until they get lower again. When I was first diagnosed, 2 yrs ago, a LCHF diet alone was enough to bring both my FBG and postprandial readings to normal. Then it took metformin, then more metformin. Now I cannot get FBG normal anymore on matter what. With my current dose of metformin plus strict LCHF I can keep it in the prediabetic range (if I eat a "normal" supper I have Continue reading >>

Align Probiotic - Crohn's Disease - Healingwell.com Forum

Align Probiotic - Crohn's Disease - Healingwell.com Forum

Shocker of all shockers, my GI, who has always said supplements were "voodoo medicine" gave me a months supply of Align probiotics. I almost fell of the exam table! Has anyone had luck with this probiotic? I am pretty happy with Primal Defense Ultra but figure it cant hurt to try the Align. I think that Align has a promo campaign with docs...my GI gave me a free sample and a coupon a while back. He is asking me to consider a probiotic, but he didn't promote one this time. Would like to hear folks opinion on pmedics brand and Align too. Align did nothing for me. Maybe if you're in remission it works OK, but when I tried it, I was in a mild flare and I could tell that it wasn't my usual probiotic. It is one of the few probiotics along with VSL-3 that have been put through studies...shown to help UC, but I don't know about CD, so it probably helps more with D. And yes, I do think the drug reps are bringing samples so that is the one that GI's hand out. I keep switching brands as I have this theory that it may be helpful to do so, but honestly, I don't know if any probiotics greatly help me. I am more prone to C than D. It's certainly worth a try! 54 yr. old female, diagnosed with Crohn's in terminal ileum Sept-Oct. 2007. Also have GERD and IBS, gastroparesis (Dx. with c.difficile 1/12- now resolved) MEDS: Pentasa- 6 500mg pills per day, Dexilant, Metamucil, colace, miralax as needed, Culturelle probiotics .25 xanax for sleep prn I never would have thought they would have put milk protein in it! Thanks for the warning SBR! I spoke to a friend with IBS and she said her Dr. was handing out Align too so the reps must be making the rounds and pushing this probiotics. Avascular necrosis bilateral knees from Prednisone. Surgery on left knee was Oct 2011, Right knee April 2013 8 Continue reading >>

Response To Metformin Pathway Bioinformatics

Response To Metformin Pathway Bioinformatics

Response To Metformin Pathway Bioinformatics Disease and disorder research has been conducted in relation to the Response To Metformin Pathway and Diabetes Mellitus, Non-insulin-dependent, Diabetes Mellitus, Polycystic Ovary Syndrome, Insulin Resistance, Obesity. The study of the Response To Metformin Pathway has been mentioned in research publications which can be found using our bioinformatics tool below. The Response To Metformin Pathway has been researched in relation to Ovulation, Secretion, Transport, Insulin Secretion, Dna Repair. The Response To Metformin Pathway complements our catalog of research reagents including antibodies and ELISA kits against AMP-ACTIVATED PROTEIN KINASE, ATM, MTOR, IGF1, INS. Response To Metformin Bioinformatics Tool Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Response To Metformin below! For more information on how to use Laverne, please read the How to Guide . Vizit , under license from BioVista Inc. We have 1228 products for the study of the Response To Metformin Pathway that can be applied to Western Blot, Flow Cytometry, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits. Continue reading >>

Metformin Complications

Metformin Complications

Not a member? Click here to search public areas I decided to try taking Metformin a couple of months ago to try to prevent another recurrence of my cancer. I was fine at first with it. I started off with a half a 500 mg. pill a day and then the doctor checked me out after a month, decided I was doing okay, and told me to go up to the whole 500 mg. pill a day. I wasn't diabetic or even pre-diabetic. This past Sunday, I developed diarrhea. On Monday, I felt fine. On Tuesday, I had it again. I chalked it up to irritable bowel syndrome because I was going to the hospital to get a steroid shot in my back. Right after that appointment, I was fine again. Yesterday, it got really bad. I saw my family doctor's PA this morning. I had blood tests which showed no infection. I'd thought I might have caught something from a neighbor who didn't feel well. The PA thinks the diarrhea is coming from the Metformin, which I realized was a possibility. He's had other patients develop it in various lengths of time after starting on it, sometimes evenafter months. He told me to stay off of it for a week and then start it up again at the lower dose. I'm to call him on Monday and let him know if the diarrhea is gone. I commented that my blood sugars seem to be running higher than usual while on the Metformin. I know someone elseon this board recentlycommented on that. He told me it was a rebound effect. The body starts pumping out its own excess sugar in response to the pill. He says that problem can usually be controlled by taking a higher dose during the day and a lower dose at bedtime. Thank you, pinky104, for reporting your experience. Please keep us informed. As Metformin gets more notice on this board, those of us who are interested in it benefit from the input of users, especially non-d Continue reading >>

Taste Of A Pill

Taste Of A Pill

Biostatistics, University of Washington, Seattle, Washington 98195 1 To whom correspondence should be addressed: Dept. of Pharmaceutics, University of Washington, H272J Health Science Bldg., Seattle, WA 98195. Tel.: 206-221-6561; Fax: 206-543-3204; E-mail: jowang{at}uw.edu. Background: Drug excretion into saliva has important clinical implications, but the mechanisms underlying salivary gland drug transport remain unclear. Results: OCT3 is highly expressed in secretory epithelial cells and mediates active metformin transport in salivary glands. Conclusion: OCT3 provides a unique pathway for metformin secretion and accumulation in salivary glands. Significance: Carrier-mediated salivary secretion can provoke drug-induced taste disturbance. Drug-induced taste disturbance is a common adverse drug reaction often triggered by drug secretion into saliva. Very little is known regarding the molecular mechanisms underlying salivary gland transport of xenobiotics, and most drugs are assumed to enter saliva by passive diffusion. In this study, we demonstrate that salivary glands selectively and highly express OCT3 (organic cation transporter-3), a polyspecific drug transporter in the solute carrier 22 family. OCT3 protein is localized at both basolateral (blood-facing) and apical (saliva-facing) membranes of salivary gland acinar cells, suggesting a dual role of this transporter in mediating both epithelial uptake and efflux of organic cations in the secretory cells of salivary glands. Metformin, a widely used anti-diabetic drug known to induce taste disturbance, is transported by OCT3/Oct3 in vitro. In vivo, metformin was actively transported with a high level of accumulation in the salivary glands of wild-type mice. In contrast, active uptake and accumulation of metformin in sa Continue reading >>

The Chicken Or The Egg: Cardiovascular Effects Of Metformin And Sulfonylureas In Type 2 Diabetes

The Chicken Or The Egg: Cardiovascular Effects Of Metformin And Sulfonylureas In Type 2 Diabetes

The Chicken or The Egg: Cardiovascular Effects of Metformin and Sulfonylureas in Type 2 Diabetes Ricchetti C, Hackett E. Ricchetti C, Hackett E Ricchetti, Charlotte, and Eve Hackett.The Chicken or The Egg: Cardiovascular Effects of Metformin and Sulfonylureas in Type 2 Diabetes. In: Linn WD. Linn W.D. Ed. William D. Linn.eds. Topics in Evidence-Based Pharmacy Practice New York, NY: McGraw-Hill; 2013. Accessed May 25, 2018. Ricchetti C, Hackett E. Ricchetti C, Hackett E Ricchetti, Charlotte, and Eve Hackett.. "The Chicken or The Egg: Cardiovascular Effects of Metformin and Sulfonylureas in Type 2 Diabetes." Topics in Evidence-Based Pharmacy Practice Linn WD. Linn W.D. Ed. William D. Linn. New York, NY: McGraw-Hill, 2013, It is well known that diabetic patients are at higher risk for cardiovascular events such as stroke or myocardial infarction (MI).1 However until 2008, companies seeking approval for new diabetes medications were not required to demonstrate cardiovascular outcomes, either positive or negative. Newer trials for diabetes medications have shown that some agents are effective at lowering blood sugar, but may actually increase the risk of cardiovascular disease (CVD).2 The concerns for the cardiovascular effects became strong enough that the FDA started requiring proof not only of efficacy in glucose-lowering, but also safety with cardiovascular outcomes for antidiabetic medications.3,4 Sulfonylureas and metformin were two medication classes not required to report their cardiovascular outcomes at the time of their approval.3 Therefore, the case of their effects on cardiovascular outcomes had gone cold. Only recently was it reopened, with the retrospective cohort study through the National Veterans Health Administration (VHA) databases.5 The investigators stu Continue reading >>

[full Text] Quality Measure Attainment With Dapagliflozin Plus Metformin Extended- | Rmhp

[full Text] Quality Measure Attainment With Dapagliflozin Plus Metformin Extended- | Rmhp

Editor who approved publication: Professor Frank Papatheofanis Background: The use of quality measures attempts to improve safety and health outcomes and to reduce costs. In two Phase III trials in treatment-naive patients with type 2 diabetes, dapagliflozin 5 or 10 mg/d as initial combination therapy with metformin extended-release (XR) significantly reduced glycated hemoglobin (A1C) from baseline to 24 weeks and allowed higher proportions of patients to achieve A1C <7% vs dapagliflozin or metformin monotherapy. Objective: A pooled analysis of data from these two studies assessed the effect of dapagliflozin 5 or 10 mg/d plus metformin XR (combination therapy) compared with placebo plus metformin XR (metformin monotherapy) on diabetes quality measures. Quality measures include laboratory measures of A1C and low-density lipoprotein cholesterol (LDL-C) as well as vital status measures of blood pressure (BP) and body mass index (BMI). The proportion of patients achieving A1C, BP, and LDL-C individual and composite measures was assessed, as was the proportion with baseline BMI 25 kg/m2 who lost 4.5 kg. Subgroup analyses by baseline BMI were also performed. Results: A total of 194 and 211 patients were treated with dapagliflozin 5- or 10-mg/d combination therapy, respectively, and 409 with metformin monotherapy. Significantly higher proportions of patients achieved A1C 6.5%, <7%, or <8% with combination therapy vs metformin monotherapy (P<0.02). Significantly higher proportions of patients achieved BP <140/90 mmHg (P<0.02 for each dapagliflozin dose) and BP <130/80 mmHg (P<0.02 with dapagliflozin 5 mg/d only) with combination therapy vs metformin monotherapy. Similar proportions (29%33%) of patients had LDL-C <100 mg/dL across treatment groups. A higher proportion of patien Continue reading >>

Metformin In Patients With Type 2 Diabetes And Kidney Disease

Metformin In Patients With Type 2 Diabetes And Kidney Disease

Go to: Abstract Metformin is widely viewed as the best initial pharmacological option to lower glucose concentrations in patients with type 2 diabetes mellitus. However, the drug is contraindicated in many individuals with impaired kidney function because of concerns of lactic acidosis. To assess the risk of lactic acidosis associated with metformin use in individuals with impaired kidney function. In July 2014, we searched the MEDLINE and Cochrane databases for English-language articles pertaining to metformin, kidney disease, and lactic acidosis in humans between 1950 and June 2014. We excluded reviews, letters, editorials, case reports, small case series, and manuscripts that did not directly pertain to the topic area or that met other exclusion criteria. Of an original 818 articles, 65 were included in this review, including pharmacokinetic/metabolic studies, large case series, retrospective studies, meta-analyses, and a clinical trial. Although metformin is renally cleared, drug levels generally remain within the therapeutic range and lactate concentrations are not substantially increased when used in patients with mild to moderate chronic kidney disease (estimated glomerular filtration rates, 30-60 mL/min per 1.73 m2). The overall incidence of lactic acidosis in metformin users varies across studies from approximately 3 per 100 000 person-years to 10 per 100 000 person-years and is generally indistinguishable from the background rate in the overall population with diabetes. Data suggesting an increased risk of lactic acidosis in metformin-treated patients with chronic kidney disease are limited, and no randomized controlled trials have been conducted to test the safety of metformin in patients with significantly impaired kidney function. Population-based studies d Continue reading >>

Metformin And Vitamin B12 Deficiency

Metformin And Vitamin B12 Deficiency

Visited for my mother. Worst experience ever. Worst facilities. Worst doctor. High fees according to service provided. Fake ratings. Ad boosted. Don't trust them. Dr Hiren has deep knowledge is his area of work. Treats every patient with utmost importance and care. Gives you proper and required treatment and every detail of your condition. Strongly recommended. very knowlegable and easy diagnostic with patients..... the way to make patients feel comfortable is very nice.... need more Dr like Dr. Hiren.... keep it up best of luck Dr. Hiren is superb by knowledge and tell minute details to each and every Patient regarding their condition and by this eay half treatment is always done by counselling.. highly recommended as a endocrinologist... My father got good control over diabetes with oral medication again. Before that he was on insulin therapy for 3 months...Thansk to Dr. Hiren He has sound knowlege.....I am very well satisfied My mother is having uncontrolled diabetes since a long time. She was taking insulin and repeatedly getting low sugars. But after consulting dr hiren, her sugars r totally under control and even her low sugar problem has also gone. And she is healthy. Very satisfying result I visited dr hiren for my wife's thyroid problem. She was having multiple complains. But after consulting dr hiren all her problems r gone. He listened each and every complains and councelled her very nicely. Now she is extremely happy and all her problems r gone.. Continue reading >>

Metformin More Effective Than Sulfonylureas For Reducing Cardiovascular Mortality In Diabetes Patients

Metformin More Effective Than Sulfonylureas For Reducing Cardiovascular Mortality In Diabetes Patients

Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients Metformin outperformed sulfonylureas in reducing CVD mortality. For patients with type 2 diabetes, metformin reduces the relative risk of cardiovascular-related mortality by 30% to 40% more than sulfonylureas, according to a meta-analysis published in the Annals of Internal Medicine. "Metformin looks like a clear winner," said Nisa Maruthur, MD, MHS, assistant professor of medicine at the Johns Hopkins University School of Medicine. "This is likely the biggest bit of evidence to guide treatment of type 2 diabetes for the next 2 to 3 years." This review provides an update to 2 previous analyses, the most recent of which was published in 2011. Since then, more than 100 new studies have compared the efficacy of blood sugar-reducing drugs, and several new drugs have been introduced. The study compared the efficacy and safety of monotherapy (thiazolidinediones, metformin, sulfonylureas, dipeptidyl peptidase-4 [DPP-4] inhibitors, sodium-glucose cotransporter 2 [SGLT-2] inhibitors, and glucagon-like peptide-1 [GLP-1] receptor agonists) and several metformin-based combinations in adults with type 2 diabetes. The researchers used data from 204 studies (179 trials and 25 observational studies) that compared monotherapies or metformin-based combination therapies. The studies were identified from MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials from inception through March 2015 (with the MEDLINE search extended through December 2015). After analyzing the data, the researchers found that cardiovascular mortality was lower in patients who used metformin comp Continue reading >>

Prescribing Attitudes, Behaviors And Opinions Regarding Metformin For Patients With Diabetes: A Focus Group Study

Prescribing Attitudes, Behaviors And Opinions Regarding Metformin For Patients With Diabetes: A Focus Group Study

Participant responses to clinical case scenarios: metformin prescribing behaviors of participants (N = 14). The nine overarching themes are described below and include use of metformin in the settings of kidney insufficiency, heart failure, hepatic dysfunction, COPD, alcoholism, current or historical lactic acidosis, and metformin dosing and contraindications. There was consensus that renal function was an important consideration when prescribing metformin, with more severe renal impairment being most concerning. Responses to the clinical case scenarios revealed that all participants would adjust metformin therapy based on either serum creatinine or GFR thresholds, with 10 of 13 indicating they would base their decision on GFR versus serum creatinine ( Table 2 ). Most participants stated that they do not calculate GFR manually because it is included in standard laboratory reports, but one individual stated they would double check accuracy. Participants stated they typically evaluate serum creatinine at annual preventative health visits, but that they would not evaluate serum creatinine more frequently in patients prescribed with metformin. Half of participants felt heart failure was an important consideration when prescribing metformin. A total of 7 of 14 participants indicated they would adjust metformin therapy based on varying severity of heart failure ( Table 2 ) in response to the clinical case scenarios. Half of participants stated they would adjust metformin if heart failure was unstable or was a primary reason for hospitalization, while the others stated they would not alter metformin therapy based solely on heart failure-related factors. However, all participants agreed that they would not change the frequency of assessing heart failure in patients taking metf Continue reading >>

Effect Of Metformin And Probiotics In Reproductive-aged Patients With Polycystic Ovary Syndrome

Effect Of Metformin And Probiotics In Reproductive-aged Patients With Polycystic Ovary Syndrome

You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Effect of Metformin and Probiotics in Reproductive-aged Patients With Polycystic Ovary Syndrome The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. ClinicalTrials.gov Identifier: NCT03336840 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Information provided by (Responsible Party): Dalong Zhu, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information The purpose of this clinical trial is to evaluate the safety and effectiveness on the clinical and biological parameters of reproductive-aged PCOS women after a 12-week metformin and/or probiotics administration. Drug: Metformin tablets Drug: ProMetS probiotics powder Drug: 1. Metformin tablets; 2. ProMetS probiotics powder Probiotics are live bacteria that offer a health benefit to the host when administered in adequate amounts. Probiotic supplementation is safe for use and has demonstrated beneficial effects for metabolic diseases such as obesity and diabetes. In this study, about 90 reproductive-aged women with PCOS will be enrolled. Participants will be randomly assigned into one of the following three groups: Metformin tablets (0.5g tid po), ProMetS probiotics powder (4g qN po), Metformin tablets (0.5g tid po) and ProMetS probiotics p Continue reading >>

More in diabetes